馬用医薬品・サプリメント市場：製品別、流通チャネル別-2025～2030年の世界予測

馬用医薬品・サプリメント市場は、2023年に9億3,052万米ドルと評価され、2024年には9億8,349万米ドルに達すると予測され、CAGR 5.78％で成長し、2030年には13億7,952万米ドルに達すると予測されています。

馬用医薬品・サプリメント市場には、馬の健康の維持・増進を目的とした医薬品、栄養サプリメント、獣医療的治療など、馬専用に配合された多様な製品が含まれます。これらの製品の必要性は、主に馬がスポーツ、農業、レジャー活動に幅広く参加し、最適な健康とパフォーマンスを要求されることから生じています。その用途は、必須栄養素の補給や関節・骨の健康管理から、特定の病状の治療まで多岐にわたります。獣医師、馬術療法士、ブリーダー、馬主が主要エンドユーザーであり、馬産業におけるこれらの製品の重要性を裏付けています。市場の成長は、馬の健康に関する意識の高まり、馬の病気の有病率の上昇、天然成分や製剤への志向の高まりといった要因に強く影響されています。さらに、馬術スポーツ産業の拡大も市場需要に大きな弾みをつけています。しかし、市場は成分コストの変動、厳しい規制状況、製品の有効性を検証するための包括的調査の必要性といった課題に直面しています。この領域におけるイノベーションは、サプリメントの先進的送達システムの開発、新規治療のためのバイオテクノロジーの進歩の活用、個別化された馬の健康管理のためのデータ分析の活用に焦点を当てることができます。また、特定の品種や病態に特化した製剤の研究開発も考えられます。このセグメントに参入する企業は、流通の強化やニッチ市場を対象とした製品ラインの拡充のために、戦略的パートナーシップや提携を検討すべきです。馬術競技が盛んになっている未開拓の地域にも潜在的なビジネス機会が存在するため、企業は市場への浸透と消費者教育を効果的に行う戦略を立てる必要があります。市場は既存企業と新興企業の両方が存在し、一貫した技術革新と品質へのこだわりが必要とされる競合環境が醸成されています。課題はあるもの、馬用医薬品とサプリメントのセグメントは、専門的でサステイナブルソリューションに対する継続的な需要に牽引され、成長を遂げようとしています。

市場力学：急速に進化する馬用医薬品・サプリメント市場の主要市場洞察を公開

馬用医薬品・サプリメント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 馬用医薬品とサプリメント製品に対する意識の高まり
  • 馬のブリーダーの間でオーガニック製品が選ばれていることによる、ハーブ飼料、消化剤、エネルギーサプリメントの需要増加
  • 競馬や馬術セグメントでの馬用サプリメントの採用拡大
• 市場抑制要因
  • 医薬品とサプリメントに関する厳しい規制
• 市場機会
  • 馬の全体的な健康とウェルネス重視の高まりと電解質サプリメントの広範な使用
  • 新しい馬用医薬品・サプリメントの開発
• 市場課題
  • 馬の健康への副作用

ポーターのファイブフォース：馬用医薬品・サプリメント市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：馬用医薬品・サプリメント市場における外部からの影響の把握

外部マクロ環境要因は、馬用医薬品・サプリメント市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：馬用医薬品・サプリメント市場における競合情勢の把握

馬用医薬品・サプリメント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：馬用医薬品・サプリメント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、馬用医薬品・サプリメント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：馬用医薬品・サプリメント市場における成功への道筋を描く

馬用医薬品・サプリメント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 馬用医薬品とサプリメント製品に関する認知度の向上
    • 馬の飼育者の間でオーガニック製品が好まれるようになり、ハーブ飼料、消化剤、エネルギーサプリメントの需要が高まっている
    • 競馬と馬術部門における馬用サプリメントの採用増加
  • 抑制要因
    • 医薬品やサプリメントに関する厳しい規制
  • 機会
    • 馬の総合的な健康とウェルネスへの重点が高まり、電解質サプリメントが広く使用されるようになった
    • 新しい馬用医薬品・サプリメントの開発
  • 課題
    • 馬の健康への副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 馬用医薬品・サプリメント市場：製品別

• イントロダクション
• 医薬品
  • 抗炎症
  • 抗潰瘍薬
  • 鎮静剤と精神安定剤
• サプリメント
  • 関節サプリメント
  • ビタミンとミネラル

第7章 馬用医薬品・サプリメント市場：流通チャネル別

• イントロダクション
• ドラッグストア
• 動物病院

第8章 南北アメリカの馬用医薬品・サプリメント市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の馬用医薬品・サプリメント市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの馬用医薬品・サプリメント市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Alltech
• Bayer AG
• Boehringer Ingelheim International GmbH
• Cargill, Incorporated
• Ceva Sante Animale
• Dechra Veterinary Products Limited
• Elanco Animal Health Incorporated
• Equineproducts-uk Ltd.
• Lallemand, Inc.
• Merck & Co., Inc.
• Purina Animal Nutrition LLC
• Thermo Fisher Scientific Inc.
• Vetoquinol USA
• Virbac
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET RESEARCH PROCESS
• FIGURE 2. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET DYNAMICS
• TABLE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-ULCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SEDATIVE & TRANQUILIZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 35. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 57. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 61. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 130. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 131. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 146. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 147. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 150. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 151. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 189. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Equine Pharmaceuticals & Supplements Market was valued at USD 930.52 million in 2023, expected to reach USD 983.49 million in 2024, and is projected to grow at a CAGR of 5.78%, to USD 1,379.52 million by 2030.

The equine pharmaceuticals and supplements market encompasses a diverse range of products that are formulated specifically for horses, including medications, nutritional supplements, and veterinary treatments aimed at maintaining and enhancing equine health. The necessity of these products emerges primarily from the extensive participation of equines in sports, agriculture, and leisure activities, which demands optimum health and performance. Applications range from providing essential nutrients and managing joint and bone health to treating specific medical conditions. Veterinarians, equine therapists, breeders, and horse owners represent the primary end-users, underlining the importance of these products in the equine industry. Market growth is strongly influenced by factors such as increasing awareness regarding horse health, the rising prevalence of equine diseases, and a growing inclination towards natural ingredients and formulations. Moreover, the expanding equestrian sports industry adds significant impetus to market demand. However, the market faces challenges such as fluctuating ingredient costs, stringent regulatory landscapes, and the need for comprehensive research to validate product efficacy. Innovations in this domain could focus on developing advanced delivery systems for supplements, leveraging biotechnological advancements for novel therapeutics, and utilizing data analytics for personalized equine health management. R&D efforts could also explore tailored formulations for specific breeds or conditions. Companies venturing into this space should consider strategic partnerships or collaborations for enhanced distribution and expanded product lines targeting niche markets. Potential opportunities exist within the untapped regions where equine sports are gaining traction, requiring companies to strategize market penetration and consumer education effectively. The market is characterized by both established firms and emerging players, fostering a competitive environment that necessitates consistent innovation and adherence to quality. Despite challenges, the equine pharmaceuticals and supplements sector is poised for growth, driven by continuous demand for specialized and sustainable solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Equine Pharmaceuticals & Supplements Market

The Equine Pharmaceuticals & Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness about equine pharmaceuticals and supplements products
  • Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
  • Growing adoption of equine supplements in horse racing and equestrian sectors
• Market Restraints
  • Stringent regulations regarding the pharmaceutical products and supplements
• Market Opportunities
  • Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
  • Development of new equine pharmaceuticals & supplements
• Market Challenges
  • Side effects on the health of equine

Porter's Five Forces: A Strategic Tool for Navigating the Equine Pharmaceuticals & Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Equine Pharmaceuticals & Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Equine Pharmaceuticals & Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Equine Pharmaceuticals & Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Equine Pharmaceuticals & Supplements Market

A detailed market share analysis in the Equine Pharmaceuticals & Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Equine Pharmaceuticals & Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Equine Pharmaceuticals & Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Equine Pharmaceuticals & Supplements Market

A strategic analysis of the Equine Pharmaceuticals & Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Equine Pharmaceuticals & Supplements Market, highlighting leading vendors and their innovative profiles. These include Alltech, Bayer AG, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Dechra Veterinary Products Limited, Elanco Animal Health Incorporated, Equineproducts-uk Ltd., Lallemand, Inc., Merck & Co., Inc., Purina Animal Nutrition LLC, Thermo Fisher Scientific Inc., Vetoquinol USA, Virbac, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Equine Pharmaceuticals & Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Pharmaceutical and Supplement. The Pharmaceutical is further studied across Anti-Inflammatory, Anti-Ulcer Drugs, and Sedative & Tranquilizer. The Supplement is further studied across Joint Supplements and Vitamins & Minerals.
• Based on Distribution Channel, market is studied across Drug Stores and Veterinary Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness about equine pharmaceuticals and supplements products
    • 5.1.1.2. Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
    • 5.1.1.3. Growing adoption of equine supplements in horse racing and equestrian sectors
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulations regarding the pharmaceutical products and supplements
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
    • 5.1.3.2. Development of new equine pharmaceuticals & supplements
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects on the health of equine
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Equine Pharmaceuticals & Supplements Market, by Product

• 6.1. Introduction
• 6.2. Pharmaceutical
  • 6.2.1. Anti-Inflammatory
  • 6.2.2. Anti-Ulcer Drugs
  • 6.2.3. Sedative & Tranquilizer
• 6.3. Supplement
  • 6.3.1. Joint Supplements
  • 6.3.2. Vitamins & Minerals

7. Equine Pharmaceuticals & Supplements Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Drug Stores
• 7.3. Veterinary Hospitals

8. Americas Equine Pharmaceuticals & Supplements Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Equine Pharmaceuticals & Supplements Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Equine Pharmaceuticals & Supplements Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alltech
• 2. Bayer AG
• 3. Boehringer Ingelheim International GmbH
• 4. Cargill, Incorporated
• 5. Ceva Sante Animale
• 6. Dechra Veterinary Products Limited
• 7. Elanco Animal Health Incorporated
• 8. Equineproducts-uk Ltd.
• 9. Lallemand, Inc.
• 10. Merck & Co., Inc.
• 11. Purina Animal Nutrition LLC
• 12. Thermo Fisher Scientific Inc.
• 13. Vetoquinol USA
• 14. Virbac
• 15. Zoetis Inc.